Citigroup Inc Medicinova Inc Transaction History
Citigroup Inc
- $196 Billion
- Q2 2025
A detailed history of Citigroup Inc transactions in Medicinova Inc stock. As of the latest transaction made, Citigroup Inc holds 591,957 shares of MNOV stock, worth $799,141. This represents 0.0% of its overall portfolio holdings.
Number of Shares
591,957
Previous 591,957
-0.0%
Holding current value
$799,141
Previous $864,000
10.3%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding MNOV
# of Institutions
27Shares Held
5.15MCall Options Held
28.5KPut Options Held
0-
Essex Woodlands Management, Inc. The Woodlands, TX1.11MShares$1.49 Million0.52% of portfolio
-
Black Rock Inc. New York, NY695KShares$938,1730.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA687KShares$926,8780.0% of portfolio
-
Geode Capital Management, LLC Boston, MA526KShares$709,9540.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA250KShares$337,6550.0% of portfolio
About MEDICINOVA INC
- Ticker MNOV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,046,200
- Market Cap $66.2M
- Description
- MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...